More Varied Deal Structures Among Healthcare Providers are Another Reason Sellers Need Competitive Auctions
More Varied Deal Structures Among Healthcare Providers are Another ...
FOCUS Investment Banking Represents Clinart in its Acquisition by Greater Cincinnati-based CTI Clinical Trial and Consulting Services
FOCUS Investment Banking (“FOCUS”), a Washington DC-based investment bank, represented Clinart, a regional CRO (Contract Research Organization) located in Dubai, in its acquisition by CTI, Clinical Trial and Consulting Services, an international CRO headquartered in Cincinnati, Ohio.
FOCUS Investment Banking Represents Tectrol in Business Sale
Washington, DC (March 13, 2015) – FOCUS Investment Banking, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services announced today that Tectrol, Inc. has been acquired by CUI Global, Inc. (NASDAQ:CUI). FOCUS represented Tectrol in the transaction.
FOCUS Investment Banking Represents Medvance Ltd. in Acquisition by NAMSA FOCUS closes another international deal in the healthcare industry
Washington, DC (January 7, 2014) FOCUS, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that its client, Medvance Ltd., has been acquired by NAMSA. FOCUS represented Medvance in the transaction, adding another international deal to its list of completed 2013 transactions.
Middle Market Investment Banking Firm, FOCUS LLC, Represents Pleiad in Acquisition by CROMSOURCE International Transaction in Life Sciences and Clinical Research Organization Industry
Washington, DC (June 4, 2012) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that Pleiad, domiciled in Stirling,Scotland, with a substantial presence in the U.S. (Cambridge, Massachusetts) has been acquired by CROMSOURCE, headquartered in Verona, Italy. FOCUS represented Pleiad in the transaction.
Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010
Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.
